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ABSTRACT
Mitochondria contain their own translation apparatus
which enables them to produce the polypeptides en-
coded in their genome. The mitochondrially-encoded
RNA components of the mitochondrial ribosome re-
quire various post-transcriptional processing steps.
Additional protein factors are required to facilitate
the biogenesis of the functional mitoribosome. We
have characterized a mitochondrially-localized pro-
tein, YbeY, which interacts with the assembling mi-
toribosome through the small subunit. Loss of YbeY
leads to a severe reduction in mitochondrial transla-
tion and a loss of cell viability, associated with less
accurate mitochondrial tRNASer(AGY) processing from
the primary transcript and a defect in the maturation
of the mitoribosomal small subunit. Our results sug-
gest that YbeY performs a dual, likely independent,
function in mitochondria being involved in precursor
RNA processing and mitoribosome biogenesis. Is-
sue Section: Nucleic Acid Enzymes.
GRAPHICAL ABSTRACT
INTRODUCTION
Oxidative phosphorylation (OxPhos) is one of the major
functions of mitochondria. A majority of the components
of the OxPhos complexes are encoded in the cell nucleus
and imported into mitochondria upon translation in the
cytoplasm. However, thirteen structural polypeptides of
the OxPhos complexes are translated within mitochondria.
These polypeptides are encoded in the human mitochon-
drial genome (mtDNA) along with the 22 tRNAs and two
rRNAs that make up the RNA components of the intra-
organellar translation apparatus.
The mtDNA is transcribed bidirectionally, generating
long polycistronic RNA strands. In the majority of cases,
mRNAs and rRNAs in the precursors are flanked by tRNA
molecules (1,2). The excision of these mt-tRNAs is per-
formed by endonucleolytic enzymes RNase P at the 5′ end,
and RNase Z (ELAC2) at the 3′ end (3,4). This releases the
mt-mRNAs and mt-rRNAs, with the latter undergoing fur-
ther maturation and assembly into the mitochondrial ribo-
some.
The mammalian mitoribosome consists of a large (mt-
LSU) and small subunit (mt-SSU), and is composed of
82 nuclear-encoded proteins, two mt-rRNAs and one mt-
tRNA(5,6). The assembly of the mitoribosome involves
the chemical modification of the mt-rRNAs, spontaneous
RNA–protein and RNA–RNA interactions and RNA fold-
ing, and requires the assistance of various assembly factors.
Several enzymes introducing post-transcriptional modifi-
cations to mt-rRNA have been recently shown to play a
role in mitoribosome assembly (7–9). The assembly fac-
tors include, but are not limited to, GTPases and ATP-
dependent RNA helicases. The hydrolysis of NTPs by
these enzymes ensure that the mt-rRNA does not fall into
conformational traps. For example, GTPBP5 (also called
OBGH1) (10,11), GTPBP6 (12), GTPBP7 (MTG1) (13)
and GTPBP10 (also called ObgH2) (14,15) are four con-
served GTPases that assist in the assembly of mt-LSU.
GTPBP5 and GTPBP10 functionally interact with other
late-stage assembly factors including NSUN4, MTERF4
and MRM2 (16,17). C4orf14 (18–20) and ERAL1 (21,22)
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are two conserved GTPases that are involved with the bio-
genesis of mt-SSU. During mitoribosome assembly, RNA
helicases such as DDX28 (23) and DHX30 (24) unwind mt-
rRNA coupled to the hydrolysis of ATP. Additional factors
such as MALSU1 form a trimeric complex with L0R8F8
and mt-ACP at the intersubunit interface preventing the as-
sociation of the immature subunits during monosome for-
mation (25–27). The early stages of mitoribosomal assem-
bly occur co-transcriptionally in the nucleoid (28). The as-
sembly of mt-LSU can initiate on the 12S–16S mt-rRNA
precursor molecule, but not the mt-SSU (29). The initiation
and progression of small subunit assembly may be inhibited
until a certain stage of early mt-LSU assembly is complete
(15,30). Then, subsequent steps of mitoribosome biogenesis
are continued in distinct foci called RNA granules (31,32).
In bacteria, the ribosomal RNAs are co-transcribed as
a single operon. The pre-rRNA undergoes the removal of
transcribed spacer regions before the rRNA is ready for as-
sembly. The bacterial homolog of human YbeY is a single
strand-specific endoribonuclease that is responsible for the
3′ end processing of the SSU rRNA (33–36). Depletion of
the protein leads to the accumulation of precursors, the loss
of the SSU and a subsequent translation defect (37,38). In
addition, the protein also plays a role in LSU rRNA and
5S rRNA maturation (34). However, recent work suggests
that, unlike other nucleases that can use immature small
subunits containing precursor 16S rRNA as substrates for
nucleolytic activity, the endonucleolytic activity of purified
bacterial YbeY on precursor 16S SSU rRNA has not been
demonstrated in vitro. Even the addition of various combi-
nations of known YbeY interactors, ribosome components
and initiator tRNA did not lead to expected YbeY-specific
RNA cleavage events (35,39). Furthermore, it has also been
implicated in the degradation of defective and misprocessed
SSU rRNA and, as such, plays a role in ribosome quality
control, in conjunction with RNase R (34,39,40).
Little is known about the human orthologue of bacterial
YbeY. Unlike bacteria, the 16S and 12S mt-rRNA com-
ponents are flanked by mt-tRNAs, and their excision by
RNase P and ELAC2, without the need for further end
processing, is sufficient for assembly into the mitochon-
drial ribosome (41). Therefore, the function of mammalian
YbeY is expected to be substantially different. Recent work
demonstrated that the introduction of human YbeY into
bacteria lacking the homolog caused partial rescue of phe-
notype (42). However, the exact function of YbeY in mam-
malian mitochondria has so far not been investigated in de-
tails.
We and others have recently shown that defects in the
structural components of mitoribosome and its assembly
factors can lead to a human disorder of mitochondrial res-
piration (43–46). The RNase activity of YbeY from vari-
ous bacterial species (34,36,47), plant chloroplasts (48) and
the mammalian mitochondria have been previously demon-
strated (42). Therefore, we have focussed on the functional
significance of the protein in the mitochondria. Here, we
show that YbeY is a mitochondrially-localized protein. We
characterize YbeY-deficient HEK293T cell lines and YbeY
knockout Hap1 cell lines. We demonstrate that the loss of
the protein leads to a severe perturbation of mitochondrial
translation. We also show that YbeY has a dual function: (i)
YbeY plays a role in tRNASer(AGY) processing at both the
5′ and 3′ ends and (ii) interacts with the mt-SSU compo-
nent uS11m. In certain growth conditions, the loss of YbeY
causes a decrease in the abundance of 12S mt-rRNA and
mt-SSU. These findings on the role of YbeY provide new
insights into the mitoribosome assembly process and, in the
long-term, can help pave the way for the development of fu-
ture mechanism-based therapies for mitochondrial diseases.
MATERIALS AND METHODS
Plasmids
The plasmid encoding the open reading frame (ORF)
of YbeY was purchased as an IMAGE cDNA clone
(IRAUp969G02109D; GeneScript Item number: SC1010)
from Source Bioscience. The YbeY ORF was equipped with
the FLAG-tag coding sequence (encoded on the reverse
PCR primer) and cloned into the pcDNA5/FRT/TO
plasmid or an untagged version was cloned into
pcDNA5/FRT/TO without or with the FLAG/Strep2
tag, as described in (49). The p32/C1QBP ORF (a
kind gift of Dr Jiuya He, MRC-MBU) was cloned into
pcDNA5/FRT/TO harbouring FLAG/Strep2 tag upon
PCR amplification. The primers used are detailed in
Supplementary Table S1.
Genome-modified cell lines
For the generation of YbeY deficient HEK293T cell lines,
the cells were transiently transfected with CompoZr ZFNs
(Sigma-Aldrich) using Cell Line Nucleofector (Lonza),
buffer kit V (Lonza) and program A-023. Seventy-two
hours after transfection, the cells were single-cloned into
96 well plates and screened using Sanger sequencing to
identify indels at the ZFN target site and western blot-
ting. Wild-type Hap1 and YbeY knockout Hap1 cell lines
were purchased from Horizon Discovery (Product ID:
HZGHC002765c022).
Cell culture
Cell lines were maintained at 5% CO2 and 37◦C in hu-
midified incubators. The HEK293T and HeLa cells were
cultured in Dulbecco’s Modified Eagle Medium (DMEM),
containing 4.5 g/l glucose, 110 mg/l sodium pyruvate,
supplemented with 10% (v/v) foetal bovine serum, 100
U/ml penicillin and 100 g/ml streptomycin. Hap1 cells
were cultured in Iscove’s modified Dulbecco’s medium
(IMDM) containing 4.5 g/l glucose, 110 mg/l sodium pyru-
vate, supplemented with 10% (v/v) foetal bovine serum,
100 U/ml penicillin and 100 g/ml streptomycin. IMDM
for YbeY knockout Hap1 cells were supplemented with
20% FBS. HEK293T/Flp-In/T-Rex cells were cultured
in supplemented DMEM with additional 15 g/ml blas-
ticidin and 100 g/ml Zeocin. After transfection with
pcDNA/FRT/TO plasmid, the cells were cultured in
supplemented DMEM containing 4.5 g/l glucose, 110
mg/l sodium pyruvate, supplemented with 10% (v/v)
tetracycline-free foetal bovine serum, 100 U/ml penicillin
and 100 g/ml streptomycin, 15 g/ml blasticidin and 50
g/ml hygromycin.
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Transfection
2 g of DNA and 3 l of Lipofectamine 2000 were incu-
bated in 100 l of OptiMEM separately for 5 minutes at
room temperature. They were mixed and incubated for a
further 10 min. Then, they were added to cells in supple-
mented DMEM and mixed by swirling.
Immunodetection of proteins
A confluent 9 cm dish of HEK293T or Hap1 cells were
washed with PBS and pelleted at 270 × g for 3 min. The pel-
let was lysed with Lysis buffer (50 mM Tris–HCl, 150 mM
NaCl, 1 mM EDTA, 1% Triton, 1× Roche inhibitor tablet)
on ice for 15 minutes and centrifuged at 6800 × g for 5 min.
The protein concentration of the supernatant was quanti-
fied. 25 g of lysate was boiled at 95◦C with 33.3% NuPAGE
LDS 4× sample buffer containing 200 mM DTT. The boiled
solution was run on a 4–12% Bis–Tris NuPage polyacry-
lamide gel at 200 V for 30 min. The proteins were trans-
ferred onto a nitrocellulose membrane with the iBlot 2 Dry
Blotting System using Protocol ‘P0’. Gels were stained with
SimplyBlue Safestain. The membrane was blocked with 5%
non-fat milk in PBS-T (Phosphate-Buffered Saline, 0.1%
Tween 20, pH 7.4) at room temperature. The membrane was
then incubated overnight at 4◦C with primary antibody di-
luted in 5% milk in PBS-T. The membrane was washed 3
times for 10 min with PBS-T. The membrane was incubated
with secondary antibody diluted in PBS-T and then washed
again as before. Finally, the membrane was developed using
ECL and X-ray film. The antibodies used for this analysis
and their dilutions can be found in Supplementary Table S2.
Mitochondrial Isolation and cell fractionation
Mitochondria were isolated using a cell homogenizer (iso-
biotec) as described by (50). For cell fractionation, the mi-
tochondrial isolation protocol that uses a Dounce homog-
enizer adapted from (49) was used. Briefly, 15 confluent 15
cm dishes of HEK293T cells were washed with 1× PBS and
pelleted. The cell pellet was resuspended in 15 ml of mito-
buffer (0.6 M mannitol, 10 mM Tris–HCl pH 7.4, 1 mM
EDTA) containing 0.1% BSA. 100 l of the cell suspen-
sion was kept aside as the ‘total fraction’. The suspension
was homogenized in a Dounce homogenizer (15 strokes)
and centrifuged at 400 × g for 10 min. The supernatant
from this step was kept aside on ice. The pellet was resus-
pended in mitobuffer containing BSA and re-homogenized
as above and centrifuged at 400 × g for 5 min. The pellet
from this step was used as the ‘Debris fraction’. The super-
natant from this step and the preceding step was centrifuged
at 11 000 × g. The supernatant from this step was kept aside
as the ‘Cytoplasm fraction’. The pellet was resuspended in
1 ml of mitobuffer containing 50 U/ml Benzonase, incu-
bated on ice for 15 min and centrifuged at 11 000 × g for 10
min. The mitochondrial pellet was resuspended in 120 l of
mitobuffer and divided into two aliquots. The first aliquot
was the mitochondrial fraction. The second aliquot was in-
cubated with 4 g/mg of Proteinase K for 30 min on ice
(proteinase K fraction). The aliquots were centrifuged at 11
000 × g for 5 min. The pellet was lysed, and all fractions
were analysed by western blotting.
Immunocytochemistry
The cells were grown on coverslips in a well of a six-well
plate. Twenty-four hours after transfection, the cells were
washed with PBS and then incubated with 4% formaldehyde
diluted in PBS for 15 min. The cells were then washed with
PBS and then permeabilized for 5 min with 0.1% Triton-X
diluted in PBS. The cells were incubated for 1 h in PBSS
(5% FBS v/v, 95% PBS) and then for 1.5 h in primary an-
tibody diluted in PBSS. The cells were washed three times
for 5 min in PBSS. Secondary antibody, diluted in PBSS,
was added to the cells and incubated for 1 h. Following
the incubation, the cells were washed (5 min each) twice in
PBSS and once in PBS and mounted in Vectashield mount-
ing medium. The cells were visualized by fluorescence mi-
croscopy using a Zeiss LSM 510 META confocal micro-
scope. The antibodies used for the immunocytochemistry
analysis and their dilutions can be found in Supplementary
Table S2.
Circularization RT-PCR sequencing
For the analysis of the 5′ and 3′ ends of certain mt-tRNAs
and mt-rRNAs, the protocol was adapted from (51). In
brief, the RNA was circularized and reverse transcribed
across the ligated junction. PCR was used to amplify the
product, which was then cloned using a Zero Blunt TOPO
PCR cloning kit and sequenced using an M13 forward uni-
versal sequencing primer. The primers for the circulariza-
tion RT-PCR are listed in Supplementary Table S1.
35S-Methionine metabolic labelling of de novo protein synthe-
sis
Newly synthesized mitochondrial proteins in Hap1 and
HEK293T cell lines were labelled with 35S-labelled methio-
nine and analysed by autoradiography as described by (16).
Immunoaffinity purification and SILAC analysis
For SILAC-based immunoaffinity purification experi-
ments, doxycycline-inducible YbeY-FLAG-expressing
HEK293T cells were grown in SILAC DMEM media
(ThermoFisher Scientific) containing heavy 15N- and 13C-
labelled L-arginine (88 g/ml) and L-lysine (152 g/ml)
or light 14N and 12C L-arginine (69 g/ml) and L-lysine
(146 g/ml) (Sigma Aldrich). This medium also contained
unlabelled L-proline (200 g/ml). Cells were differentially
induced with 100 ng/ml doxycycline for 24 h. The four
conditions: heavy induced (HI), heavy uninduced (HU),
light induced (LI), light uninduced (LU) were harvested,
pelleted at 270 × g for 3 min, washed with PBS and
re-pelleted. Uninduced cells were used as control. The
cells were quantified and mixed in equal proportion as
follows: HI with LU (control) and LI with HU (control).
Mitochondria were isolated (see Mitochondrial isolation
section) from the cell suspension. Mitochondria were lysed
and immunoaffinity purification was carried out with
FLAG M2 affinity gel (Sigma-Aldrich) following manu-
facturer’s instructions. Elution was performed with FLAG
peptide. The samples were analysed with LC–MS/MS on a
Thermo Scientific Q Exactive Plus mass spectrometer and
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Proxeon EASY-nLC 1000 chromatography. The internal
‘lock mass’ standard of 445.120 m/z was used for accurate
mass measurements. Proteins were identified using the
ANDROMEDA algorithm of the MAXQUANT software
package by comparing the proteins to the human UniProt
database. The peptide information from both sets were
combined and filtered using the PERSEUS software,
removing proteins only identified by site, that matched
a decoy peptide database and contaminating peptides.
Proteins identified by two or fewer peptides were removed.
Ratios for both reciprocal samples, i.e. HI/LU and LI/HU
and a base two logarithm (log2) were calculated. The data
was plotted on an X–Y scatter plot. The positive values
for both log2 ratios (protein ID present in the top right
quarter of the X-Y scatter plot) indicate interaction in the
reciprocal experiments.
For non-SILAC immunoprecipitation experiments, the
unlabelled induced cell expressing YbeY-FLAG/Strep2
were subjected to mitochondrial isolation and FLAG im-
munoaffinity purification, as described above. The sam-
ples were run on SDS-PAGE, the gel was stained for 1 h
with SimplyBlue Safestain (ThermoFisher Scientific) and
destained for 1 h using 20% methanol and 10% acetic acid
solution. Visually identifiable bands were excised and sub-
mitted for analysis by mass spectrometry as described pre-
viously (49).
Quantitative density gradient analysis by mass spectrometry
(qDGMS) and complexome profiling analysis (ComPrAn)
In order to study mitoribosome composition and assem-
bly in YbeY-KO Hap1 cells we used quantitative density
gradient analysis by mass spectrometry (qDGMS) generally
as described in (52). In this method, complexes are sepa-
rated in near-native form by density gradient ultracentrifu-
gation and SILAC enables simultaneous quantitative pro-
teomic analysis of two biological samples. Samples were
analysed with LC–MS/MS on a Thermo Scientific Oribi-
trap LTQ XL spectrometer with a nanospray inlet inter-
face coupled with Proxeon Easy II nLC chromatography.
Peptides were identified and quantified from raw data in
Proteome Discoverer (Thermo Scientific). We further used
the ComPrAn (complexome profiling analysis) R package
to analyse and visualize the qDGMS datasets. The general
approach to protein abundance estimation, normalization
and data presentation in ComPrAn is based on the prin-
ciples routinely used for the analysis of published SILAC
complexome profiling experiments (53–55). The only differ-
ence from the published qDGMS protocol (52), was in-gel
trypsin digestion, rather than digestion upon sample precip-
itation. Briefly, 100 l sucrose gradient fractions were taken
and run approximately 4 mm into a 4–12% Bis–Tris poly-
acrylamide gel to remove the sucrose. The gel was stained
for 1 hour with SimplyBlue Safestain and destained for 1
hour (20% methanol, 10% acetic acid). The stained 4 mm
gel region was cut and peptides from these gel slices were
analysed by mass spectrometry following trypsin digestion
as described in (52). The proteomics data are be available
through CEDAR (www3.cmbi.umcn.nl/cedar/), an openly
accessible database for depositing and exploring mass spec-
trometry data from complexome profiling studies. Compat-
ibility and reusability of the data is ensured by a standard-
ized reporting format containing the ‘minimum informa-
tion required for a complexome profiling experiment’ (MI-
ACE).
RNA isolation, northern blotting and RT-qPCR
RNA was extracted from HEK293T and Hap1 cell lines
with TRIzol reagent (ThermoFisher Scientific) according to
manufacturer’s instructions. Northern blot was performed
as described by (49) with minor modifications. Total RNA
was resolved on a 6% or a 15% urea–PAGE gel (for mt-
tRNAs). After wet transfer of the RNA to a nylon mem-
brane (Magnoprobe, 0.45 ; GE Healthcare or Genescreen-
plus, NEN DuPont) in 2 x SSC (150 nM NaCl, 15 mM
sodium citrate pH 7.0), the membrane was subjected to UV-
crosslinking (0.12 J). High resolution tRNA gels were dry
blotted using the ‘rapid transfer method’ where a dry nylon
membrane is placed directly on the gel for 3 minutes and
the RNA is UV-crosslinked to the membrane. The mem-
branes were hybridized overnight at 65◦C with radioac-
tively labelled PCR fragments corresponding to the anal-
ysed mt-mRNA or T7 in vitro transcribed RNA probes
corresponding to appropriate mt-tRNAs in 7% SDS and
0.25 M sodium phosphate buffer (pH 7.6), and washed with
SSC (containing 0.1% SDS) five times for 20 minutes. The
membrane was exposed to a storage phosphor screen (GE
Healthcare), visualized using a Typhoon phosphorimaging
system and quantified using ImageJ (http://imagej.nih.gov/
ij).
Measurements of RNA steady-state levels by reverse
transcription quantitative PCR (RT-qPCR) was performed
as described previously (8). Briefly, RNA was extracted with
TRIzol reagent (Thermo Fisher Scientific) and treated with
TURBO DNase (Ambion) according to manufacturer’s in-
structions. 1 g RNA was reverse transcribed using Omnis-
cript RT kit (Qiagen) with 0.5 M random hexamers and
0.5 M oligo dT primers. RT-qPCR primer and probe se-
quences can be found in Supplementary Table S1.
RESULTS
YbeY is a mitochondrial protein with a conserved endonucle-
ase domain
Human YbeY is an uncharacterized protein that is encoded
by the C21orf57 gene. It belongs to the UPF0054 protein
family (PFAM accession number: PF02130) which contains
a highly conserved zinc ion-coordinating consensus mo-
tif H3XH5XH (56). The bacterial homolog is an active
endoribonuclease and contains the RNA-binding Arg59
residue and the histidine triad (34,40). Sequence alignment
from multiple species (Figure 1 and Supplementary Fig-
ure S1) and homology modelling of human YbeY, using
the Escherichia coli protein as the template, revealed strong
conservation, especially of the aforementioned active site
residues, suggesting that human YbeY is an active RNase
(Figure 1B). In addition, the previous analysis showed that
E. coli Asp85 (Asp90 Homo sapiens), found in the beta-sheet
outside the active site and required for the interaction of
YbeY with the ribosomal small subunit component, S11, is
also conserved. Mutation of these residues has been shown
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Figure 1. Sequence/structure conservation and mitochondrial localization of human YbeY. (A) Alignment of protein sequences of the orthologues of
YbeY. The catalytically-important RNA-binding arginine is indicated a black triangle above. Green circles indicate histidine residues from the zinc ion-
binding H3H5XH motif. An orange diamond above indicates the D90 required for the interaction with ribosomal SSU component S11. Colons and dots
denote chemical similarity between the sequences; asterisks indicate identical residues. (B) Homology modelling of the human YbeY using E. coli YbeY
as a template (PDB: 1XM5) superimposed on each other: human YbeY (Yellow), conserved catalytically important residues (red) and zinc ion (green).
Eukaryote-specific insertion (Gly75-Pro83 in H. sapiens) is indicated. (C) FLAG-tagged YbeY was transiently expressed in HeLa cells and visualized using
anti-FLAG antibody (green) and the mitochondrial outer membrane translocase, TOM20 (red). Co-localization is shown in yellow. The white scale bar
at the bottom right depicts 10 m. (D) Subcellular fractionation of HEK293T cells shows YbeY protein in the same fraction as NDUFS1 (mitochondrial
inner membrane) and TOM22 (mitochondrial outer membrane, truncated by proteinase K), but not with GADPH (cytoplasm)
to disrupt nuclease activity of the protein and rRNA mat-
uration (42) (Supplementary Figure S1). Further compari-
son of the two homologs also shows that human YbeY has a
nine amino acid insertion (Gly75–Pro83) between two con-
served beta sheets which is conserved in other eukaryotic
species (Supplementary Figure S1) and may be responsible
for additional protein interactions and additional functions
in the mitochondria (Figure 1B) (42).
YbeY has been previously predicted to be mito-
chondrially localized by large-scale databases, MitoCarta
and MitoMiner 4.0 (57,58). Furthermore, large-scale
CRISPR/Cas9 screen has revealed that YbeY is vital for
OXPHOS function (59). In accordance with these results,
in silico analysis of the subcellular localization of the pro-
tein by multiple online tools predicted a high probabil-
ity of mitochondrial localization: Predotar (60)––0.87, Tar-
getP (61)––0.86, and Mitoprot (62)––0.96. To confirm these
predictions, we used immunostaining that showed a co-
localization of transiently-expressed FLAG/Strep2-tagged
YbeY to the mitochondria in HeLa cells (Figure 1C).
We also used subcellular fractionation and immunoblot-
ting to localize endogenous YbeY in the cell. YbeY co-
fractionated with inner membrane-localised Complex I sub-
unit, NDUFS1 (Figure 1D). To assess, if YbeY co-localizes
within mitochondrial RNA granules (MRGs), where pro-
cessing of nascent RNA occurs, immunocytochemistry
was performed using antibodies against a MRG marker
GRSF1 (63). While the MRGs appeared as distinct puncta,
YbeY-FLAG/Strep2 was distributed throughout the mito-
chondria (Supplementary Figure S2). However, the diffuse
spread of YbeY could be attributed to over-expression of
the protein or due to multiple functions of the protein in
the mitochondria. Taken together, this confirms that YbeY
is a mitochondrial protein and may not co-localize within
MRGs.
YbeY is required for mitochondrial translation
In order to investigate the role of YbeY, we inactivated its
expression in human cells. YbeY-deficient HEK293T cell
lines were generated using zinc finger nuclease (ZFN) tar-
geting exon 2, whereas YbeY knockout Hap1 cells were cre-
ated by CRISPR/Cas9. We found that HEK293T shows
a high degree of polyploidy at the YbeY locus of chromo-
some 21. One of the investigated HEK293T cell lines with
modified YbeY locus contained two out-of-frame deletions,
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one start-loss deletion and one allele with a 12 bp deletion
and a change in 4 amino acids. This cell line is hereby re-
ferred to as YbeY (–/m) (Supplementary Figure S3A). The
second HEK293T cell line with YbeY locus edited by the
ZFN contained the three alleles with indels which led to
premature stop codons, one allele contained an in-frame
deletion leading to a loss of two amino acids and one allele
had unmodified sequence. We named this HEK293T mu-
tant YbeY (+/–) (Supplementary Figure S3B). We also used
a near haploid, Hap1, YbeY knockout (YbeY-KO) cell line
that contained a 31 bp insertion and 1bp mutation (Sup-
plementary Figure S3C) which produces a premature stop
codon and leads to an 80 amino acid truncated protein. All
three YbeY-deficient cell lines exhibited severely depleted
levels of endogenous protein. In all three cell lines, the ex-
pected truncated proteins were not observed in the west-
ern blots possibly due to nonsense-mediated mRNA decay
or loss of the relevant epitope for antibody recognition. A
non-specific cross-reacting protein band is observed in the
HEK293T cell lines that is not present in the Hap1 cell line
western blot (Figure 2A, B). This is attributed to the dif-
ference in gene expression profiles in the different cell lines.
A lower molecular weight band is observed in YbeY-KO
western blot against native YbeY protein. This is a non-
specific cross-reacting protein that is not the correct size to
be the truncated protein (Figure 2B). We believe that this is
a YbeY knockout-specific product of altered gene expres-
sion.
Next, we intended to study the OXPHOS function and
mitochondrial translation upon ablation of YbeY. West-
ern blot analysis showed a strong reduction in the steady
state levels of Complex I and IV subunits in YbeY(–/m)
HEK293T cells (Figure 2A). A much stronger effect was
observed in the complete knockout cell line where, in ad-
dition to Complex I and IV, a Complex III subunit was
also depleted, suggesting a defect in synthesis of the OX-
PHOS subunits in the absence of YbeY. Consistent with this
result, cell growth was compromised when YbeY-deficient
HEK293T cells were grown in media containing galactose
as the sole carbon source, forcing them to rely on mitochon-
drial ATP production (Supplementary Figure S4A). The
growth of YbeY-KO Hap1 cells was compromised on stan-
dard, glucose-containing medium while the cells failed to
grow on medium containing galactose as the sole carbon
source (Supplementary Figure S4B). The effect of YbeY de-
pletion on mitochondrial translation was assessed using in
vivo incorporation of [35S]-methionine into newly synthe-
siszed proteins. A global mitochondrial translation defect
was observed in the YbeY-KO cells, while a reduction of
protein synthesis was observed in the YbeY(–/m) cells (Fig-
ure 2C, D). Moreover, in YbeY-deficient HEK293T cells,
the higher molecular weight translation products were af-
fected to a greater degree than the lower molecular weight
products (Supplementary Figure S4C). This preferential de-
pletion of longer translation products may be a result of
a detrimental effect on translation elongation. This effect
of defective RNA processing on mitochondrial translation
has been previously observed and suggests that it is not
specific to the lack of YbeY but rather a result of trans-
lation dysfunction (51). To confirm that the strong mito-
chondrial translation defect observed in the YbeY-KO cells
was not a consequence of decreased cytoplasmic trans-
lation, we repeated the labelling experiment without any
translation inhibitors or in the presence of chloramphenicol
(CAP) that inhibits mitochondrial translation. We observed
that global translation was not affected by the ablation of
YbeY (Supplementary Figure S4D, lanes 1 and 2). The
observed decrease of cytoplasmic translation in YbeY-KO
was attributed to the prolonged exposure to the competi-
tive inhibitor CAP required to completely inhibit mitochon-
drial translation (Supplementary Figure S4D, lanes 3–4).
This showed that the loss of translation was mitochondria-
specific and not caused as a by-product of reduced cyto-
plasmic translation. Taken together, these result show that
YbeY is indispensable for mitochondrial translation in hu-
man cells.
YbeY is required for accurate mt-tRNASer(AGY) processing
Given the strongest effect on mitochondrial translation and
a complete ablation of YbeY in the Hap1 YbeY-KO cells,
this cell line has been taken forward for further investiga-
tions. Next, we set out to investigate if human YbeY has a
role in controlling mitochondrial transcript steady-state lev-
els in YbeY-KO Hap1 cells. Northern blot analysis showed
that there was no substantial difference in the levels of mi-
tochondrial mRNAs relative to Hap1 control cells (Figure
3A, Supplementary Figure S5). Any observed increase in
mt-mRNAs coding for Complex I subunit ND1 and ND2
steady state levels and a decrease in mt-mRNAs encoding
Complex IV subunit CO1 and CO2 (Figure 3A, Supplemen-
tary Figure S5) was not attributed to YbeY deficiency, as a
similar compensatory phenotype has been often observed
in cells responding to defective mitochondrial translation
(51,64–66).
Further analysis of mitochondrial tRNA in YbeY-KO
Hap1 cells using high resolution northern blotting showed
a potential steady-state decrease and/or processing defect
of mt-tRNASer(AGY) relative to other mt-tRNAs analysed
(Figure 3B). Given that bacterial YbeY is predominantly
involved in rRNA end processing, we wanted to investigate
the effects of YbeY knockout on the 5′ and 3′ ends of the
mt-rRNAs and mt-tRNAs to see if YbeY plays a similar
role in the mammalian mitochondria. To do so, we used
circularization RT-PCR to ligate the 5′ end of the RNA
molecule to the 3′ end and sequence the junction. Of the
RNAs analysed, no significant difference was observed in
the 5′ and 3′ processing of mt-tRNAIle, mt-tRNALeu(UUR),
12S mt-rRNA and 16S mt-rRNA when Hap1 parental cells
and YbeY knockout Hap1 cells were compared (Figure 4A,
B). However, in YbeY knockout Hap1 cells, only ∼1% of
the mt-tRNASer(AGY) molecules were correctly cleaved from
the primary transcript and modified to add the 3′ CCA, as
compared to the ∼85% in the control Hap1 cells (Figure
4A). Sequence analysis of the mt-tRNA processing in the
YbeY knockout Hap1 cells revealed that only ∼20% of mt-
tRNASer(AGY) were correctly processed from the 5′ termi-
nus and ∼64% from the 3′ end (Figure 4C, D). This con-
firms that YbeY is required for the correct end processing
of mt-tRNASer(AGY). However, due to the limited number of
RNAs that could be studied and the limitations of the circu-
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Figure 2. Reduced mitochondrial gene expression and growth in cells lacking YbeY. (A) Analysis of steady state levels of endogenous YbeY and OXPHOS
subunits in HEK293T parental, with cells that have 1 functional copy of YBEY gene (+/–) and YbeY-deficient (-/m) cells. The asterisk denotes an unrelated
cross-reacting protein band. Coomassie Blue staining (CBS) was used as loading control. (B) Analysis of steady state levels of endogenous YbeY and
OXPHOS subunits in Hap1 parental and YbeY-KO cells. TOM22 was used as a loading control. (C) Metabolic labelling of mitochondrial translation
products with [35S]-methionine in HEK293T parental cells, YbeY (+/–) and YbeY (–/m) cell lines. Coomassie Blue staining (CBS) was used as loading
control. (D) De novo protein synthesis of Hap1 parental cells and YbeY-KO cells. Coomassie Blue staining (CBS) was used as loading control.
Figure 3. Steady state levels of mitochondrial RNA in YbeY depleted cells.
(A) Steady-state levels of mitochondrial mRNAs quantified by northern
blotting in Hap1 control and YbeY knockout Hap1 cells grown in standard
IMDM medium. 5S RNA was used as a loading control. Quantification
of steady state levels was performed using Image J and normalized to the
5S RNA loading control and values from Hap1 control cells. * P < 0.05,
One sample t-test, Error bars = 1 SD. (B) High resolution northern blot
analysis of mitochondrial tRNAs from Hap1 control and YbeY knockout
Hap1 cells. n = 2.
larization RT-PCR method, it is possible that YbeY is also
involved in the processing of other mitochondrial tRNAs.
YbeY interacts with mitochondrial ribosomal components
In order to study a potential interaction of human YbeY
with the mitoribosomal subunits, we used western blot
analysis after sucrose gradient fractionation of human
HEK293T cells. A majority of the endogenous YbeY was
found in the ‘free protein’ fractions (Figure 5A, fractions
1–4). However, a small proportion co-migrated with the
mt-SSU, suggesting potential weak interaction of YbeY
with this subunit (Figure 5A, fractions 6–9). Next, we per-
formed YbeY pull-down experiments, upon overexpression
of a FLAG/Strep2-tagged version of the protein (Supple-
mentary Figure S6A), followed by identification of poten-
tial interactors by mass spectrometry upon resolving the
eluates on SDS-PAGE (Supplementary Figure S6B). We
only detected the mitochondrial chaperones, p32/C1QBP
and HSPA9/GRP75, being pulled-down in this experiment
(Supplementary Figure S6B), which were observed pre-
viously as common contaminants in this type of exper-
iment (19,49). To study the potential YbeY-p32/C1QBP
interaction further, we performed a reciprocal experiment
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Figure 4. YbeY depletion causes defects in mt-tRNASer(AGY) end processing. (A) Results of circularization RT-PCR analysis of mt-tRNAIle, mt-
tRNALeu(UUR), mt-tRNASer(AGY), 12S mt-rRNA and 16S mt-rRNA from Hap1 control and YbeY knockout Hap1 cells. DNA bands obtained in the
circularization RT-PCR reaction were analysed by Sanger sequencing upon cloning. Number of clones analysed in each sample is given above each bar.
Analysis of significance was calculated using Fisher’s exact test. ****P < 0.0001. (B) The length of the 12S and 16S mt-rRNAs calculated from the 5′ and
3′ ends. The lines indicate the minimum and maximum values and the edges of the boxes indicate the upper and lower quartile. The middle line indicates
the median. The number of data points are written above the box and whisker plots. Significance was assessed using an unpaired Student’s t-test (n.s., not
significant). (C) Mapping of the sequence of the 5′ and 3′ ends of circularized mt-tRNASer(AGY) in Hap1 parental and YbeY knockout Hap1 cells. The
5′ and 3′ ends were plotted independently as a percentage of the total 5′ and 3′ reads sequence, respectively. (D) Proportion of mt-tRNASer(AGY) that are
correctly or incorrectly cleaved from the primary transcript at the expected ends and modified (or not) to have a 3′ CCA.
with FLAG/Strep2-tagged p32/C1QBP. We did not de-
tect YbeY being pulled-down with p32/C1QBP used as
a bait (Supplementary Figure S6C). Next, in order to
identify interactors of human YbeY with a higher sen-
sitivity, we used quantitative SILAC-based immunoaffin-
ity purification of FLAG-tagged YbeY in a doxycycline-
inducible HEK293T cell line, using uninduced cells as con-
trol. Since we did not see a reciprocal non-SILAC pull-
down, we decided to remove the Strep2 tag in case it was
somehow contributing to the observed YbeY-p32/C1QBP
interaction. The dox-induced expression levels of YbeY-
FLAG/Strep2 and YbeY-FLAG were comparable (Sup-
plementary Figure S6A). Reciprocal SILAC experiments
identified various mt-SSU and mt-LSU components be-
ing pulled-down with YbeY. The strongest interactor of
YbeY appeared to be uS11m. Other weaker interactors of
YbeY included ERAL1 and several mitoribosomal pro-
teins such as uL2m, uL4m, bL20m, bL21m, mL42, mL43,
mL50, mL64 and mS26 (Figure 5B, Supplementary Fig-
ure S6D, E, Supplementary Dataset 1). The interaction
with uS11 and ERAL1 is highly conserved in bacteria
and vital for the maturation of the small subunit (67). Of
note, while HSPA9/GRP75 was found to be slightly en-
riched in the YbeY-FLAG SILAC-based, quantitative im-
munoaffinity purification experiments, there was no sub-
stantial enrichment of p32/C1QBP (Figure 5B). On the
whole, these results show conserved interactions of YbeY
with the ribosome and, hence, a potentially conserved
role in ribosome biogenesis between bacteria and human
mitochondria.
Loss of YbeY impairs mitoribosome assembly
In E. coli, YbeY is responsible for ribosomal quality con-
trol. With the assistance of exonuclease RNase R, bacte-
rial YbeY degrades rRNA from late stage ribosome as-
sembly intermediates with defective small subunits (34,40).
Hence, we intended to investigate the effect of YbeY de-
pletion on the mitoribosome integrity. To quantitatively as-
sess changes in composition and integrity of the mitori-
bosome in the YbeY knockout Hap1 cells, we used our
recently developed complexome profiling pipeline that in-
volves quantitative density gradient analysis by mass spec-
trometry (qDGMS), in combination with the data analy-
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Figure 5. Human YbeY interacts with uS11m. (A) Analysis of the interaction of endogenous YbeY with the mitochondrial ribosome using isokinetic
sucrose gradient fractionation with mitochondria from Hap1 parental cells, and western blotting. Fractions containing unassembled free protein, the
subunits at various stages of assembly, and the associated mitoribosome are indicated above. Antibodies against mS40 and bL12m were used to identify
the fractions containing the small and large mitoribosome subunits, respectively. (B) Immunoaffinity purification of FLAG-tagged YbeY was performed
from doxycycline induced or uninduced, differentially labelled cells (please see Materials and Methods). Base two logarithm (Log2) of the ratio of peptide
abundance in induced cells (I) to peptide abundance in uninduced (U) cells were plotted on the X and Y axes from reciprocal experiments that used heavy
(H) or light (L) amino acid labelled cells. Log2(HI/LU) indicates the base two logarithm of the ratio of peptide abundance from doxycycline induced cells
labelled with 15N and 13C L-arginine and L-lysine to peptide abundance of uninduced cell labelled with 14N and 12C L-arginine and L-lysine. Log2(LI/HU)
indicates the base two logarithm of the ratio of peptide abundance from doxycycline induced cells labelled with 14N and 12C L-arginine and L-lysine to
peptide abundance of uninduced cell labelled with 15N and 13C L-arginine and L-lysine. Proteins in the top right quadrant (indicated in light grey) are those
that were enriched in the YbeY-overexpressing HEK293T cell line in both labelling experiments and proteins in the lower left quadrant are those that are
more abundant in the control cell line. Mt-SSU components (yellow diamonds), mt-LSU components (orange diamonds), p32/C1QBP (green diamond)
and other proteins (grey diamonds).
sis R package – ComPrAn (52). The qDGMS experiments
revealed that levels of assembled mt-SSU were decreased
by ∼50% in the YbeY knockout cells (Figure 6A, C, Sup-
plementary Dataset 2), while mt-LSU was generally more
abundant in the knockout cells relative to the control Hap1
cells (Figure 6B, D, Supplementary Dataset 2). Next, we fo-
cused on the analysis of the main YbeY interactor uS11m.
We did not detect any uS11m peptides in the YbeY-KO
samples in the qDGMS experiment, however uS11m was
detected in the control (Supplementary Figure S7, Supple-
mentary Dataset 3). This result is consistent with a very low
level of uS11m (below MS detection limit) in the assem-
bled mt-SSU upon ablation of YbeY. To verify this, we per-
formed western blot analysis of YbeY-KO Hap1 cells and
indeed observed a severe decrease in the steady-state lev-
els of uS11m (Supplementary Figure S8A). This analysis
also showed a decrease in the steady-state levels of other
mt-SSU components, while the steady-state levels of mt-
LSU remained largely unchanged, as compared to a con-
trol (Supplementary Figure S8A). To further verify the ef-
fect of YbeY inactivation on the assembly of uS11m into
mt-SSU, we performed western blot analysis upon sucrose
gradient fractionation using Hap1 parental and YbeY-KO
Hap1 cells. We observed a severe decrease in abundance
of uS11m in the fraction corresponding to mt-SSU (Fig-
ure 6E). Consistent, with the qDGMS results, this experi-
ment also showed the general reduction in the abundance
of the assembled mt-SSU (Supplementary Figure S8B, C).
Additional analysis also revealed a substantial decrease in
12S mt-rRNA steady-levels when the YbeY-KO Hap1 cells
were grown in SILAC IMDM medium, consistent with the
qDGMS data (Figure 6F). Of note, this decrease in steady-
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Figure 6. Assembly of mt-SSU is perturbed in YbeY knockout Hap1 cells. (A, B) Quantitative mass spectrometry analysis of mt-SSU (A) and mt-LSU
(B) in the parental and YbeY KO Hap1 cells. The samples were subjected to quantitative density gradient analysis by mass spectrometry (qDGMS) and
raw data were processed with Proteome Discoverer and further analysed in the ComPrAn R package (52). Representative peptides for each protein are
selected on the basis of being present in the highest number of fractions, for both labelling states considered together. Thus, for any given protein, the
representative peptide is the same for both labelling states. A representative peptide was not selected for proteins that do not have shared peptides or are
not present in both labelling states––these proteins are not shown. Each row represents a different mitoribosomal component. Each column represents
the fractions taken from the sucrose gradient going from 10% sucrose in fraction 1 to 30% sucrose in fraction 22. Grey squares represent the absence of
detection of a protein in a given fraction. (C, D) Quantitative comparison of the average abundance of the mt-SSU (C) and mt-LSU (D) components in
the sucrose gradient in YbeY-KO and Hap1 WT cells. (E) Analysis of the abundance of uS11m and mS40 in the mt-SSU fractions using isokinetic sucrose
gradient fractionation and western blotting in YbeY-KO and Hap1 WT cells. * and ** denote unspecific protein bands detected by anti-uS11m antibody. (F)
RT-qPCR determination of transcripts levels in Hap1 YbeY-KO cells grown in IMDM medium for SILAC. Steady-state levels of 12S and 16S mt-rRNA
were normalized to GAPDH and are presented as values relative to Hap1 wild-type control cells. n = 3. Error bars indicate SEM. P = 0.066––statistical
analysis was carried out using a two-tailed Student’s t-test.
state levels of 12S mt-rRNA was not observed for the YbeY-
KO Hap1 cells cultured in standard IMDM medium (Sup-
plementary Figure S9). Taken together these experiments
indicate that the loss of YbeY reduces the assembly or sta-
bility of mature mt-SSU leading to mitochondrial transla-
tion impairment.
DISCUSSION
The translation of the mitochondrially-encoded polypep-
tides requires the coordinated action of numerous factors.
Many of these factors act at the RNA level such as cleaving
the primary transcript, chemically modifying mt-tRNAs
and mt-rRNAs, or chaperoning the mt-rRNA into the cor-
rect conformation (68). Here, we have identified YbeY,
a mitochondrially-localized protein with a conserved en-
donucleolytic domain. Deletion of the gene led to decreased
steady state levels of the OxPhos complexes which have
mitochondrially-encoded components. Moreover, analysis
of de novo mitochondrial protein synthesis showed that
YbeY depletion had a detrimental effect on ribosome ac-
tivity.
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The main catalytic residues involved in endonucleolytic
cleavage, are conserved in mammalian YbeY suggesting the
conservation of its endonucleolytic function (42). More-
over, YbeY has been shown to be an active RNase in var-
ious bacterial species (34,36,47) and in plant chloroplasts
(48).In E. coli, similar to the mitochondria, the ribosomal
RNAs are initially transcribed within a primary transcript
and are later released through multiple hierarchical cleav-
age events. Bacterial YbeY is responsible for the 5′ and 3′
end maturation of the 16S (small subunit rRNA) precursor,
the 5′ end maturation of the 23S (large subunit rRNA) pre-
cursor and the final steps of 5S rRNA maturation (40). In
the mammalian mitochondria, however, the excision of the
flanking mt-tRNAs by RNase P and ELAC2 produces the
mt-rRNAs ready for mitochondrial assembly. Thus, to in-
vestigate if the translation defect was due to errors in RNA
processing, we investigated the effect of YbeY depletion on
RNA steady state levels. We observed no substantial differ-
ences in mRNA steady-state levels or processing, however,
there was a noticeable impact on mt-tRNASer(AGY), and mt-
tRNALeu(UUR) to a lesser extent. Analysis of the 5′ and 3′
termini of the mt-tRNAs showed a severe deficiency in ac-
curate post-transcriptional processing of mt-tRNASer(AGY)
from the primary transcript in YbeY-deficient cells. How-
ever, there are various drawbacks to the circularization RT-
PCR that we used to analyse the 5′ and 3′ termini of the
mt-tRNAs which may have led to a large variation in data
points acquired for the different tRNAs. Any misprocessed
mt-tRNA smaller than the size of the primers was not likely
to be detected. Moreover, the ligation reaction would be bi-
ased towards misprocessed RNAs with weaker secondary
structures depending on their size and composition. There-
fore, the proportion of misprocessed to correctly processed
RNAs would be higher than that present in living cells,
which may have influenced the proportion of misprocessed
mt-tRNAs observed for mt-tRNAIle and mt-tRNALeu(UUR).
Normally, the 5′ end of RNAs in the mitochondrial primary
transcripts is processed by RNase P before the 3′ end pro-
cessing by RNase Z (3,29). However, previous work has sug-
gested that mt-tRNASer(AGY) is not processed completely at
the 5′ end by RNase P (69). The authors suggested that the
release of the 5′ end of the mt-tRNA is a consequence of the
3′ endonucleolytic processing of the upstream mt-tRNAHis,
while the presence of the downstream mt-tRNALeu(UUR)
was dispensable for mt-tRNASer(AGY) 3′ end processing (69).
Furthermore, transcriptomic analysis of RNase P-deficient
MRPP3 knockout mice show that mt-tRNASer(AGY) is not
affected by the lack of RNase P (29) while the presence of
ELAC2 is required for the processing of mt-tRNASer(AGY)
as loss of the enzyme leads to accumulation of unprocessed
precursors (70). Here, we demonstrate that in the absence
of YbeY, steady state levels of mt-tRNASer(AGY) are re-
duced, and the 5′ and to a lesser extend the 3′ ends of mt-
tRNASer(AGY) are erroneously processed. However, a small
proportion of correctly processed mt-tRNAs are still pro-
duced and can be used in translation. We suggest that YbeY
may work in conjunction with ELAC2 to accurately cleave
the mt-tRNA at the 3′ end of the upstream mt-tRNAHis
and at the 3′ end of mt-tRNASer(AGY). However, we do not
observe a direct interaction between YbeY and ELAC2. It
is unclear if YbeY directs tRNA processing through direct
cleavage or with the assistance of additional factors. It is
also possible that the tRNA is correctly processed by RNase
P and ELAC2 but then undergoes exonucleolytic cleavage
in the absence of YbeY. Moreover, due to the limited num-
ber of mt-tRNAs studied, it cannot be excluded that YbeY
facilitates the processing of other mt-tRNAs.
In addition to RNA processing, the bacterial YbeY de-
grades rRNA from late stage ribosomes with defective small
subunits and as such is responsible for quality control
(34,40). We show that, in the mammalian mitochondria,
YbeY is crucial for the integrity of the small subunit. The
knockout of YbeY leads to a depletion of mt-SSU as anal-
ysed by a quantitative proteomics approach and western
blotting. The reduced steady-state levels of mt-SSU in the
Hap1 cells lacking YbeY is accompanied with a concur-
rent decrease in steady-state levels of 12S mt-rRNA (Figure
6E), while the ends of 12S mt-rRNA are correctly processed
(Figure 4, Supplementary Figure S8A). Of note, the reduc-
tion in 12S mt-rRNA was only seen in SILAC medium,
containing dialysed foetal bovine serum, but not in stan-
dard medium. This intriguing growth condition-depended
effect on RNA metabolism in mitochondria has been ob-
served before, with culturing Hap1 cells in SILAC medium
generally reducing mt-RNA steady-state levels (8). It would
be interesting to compare mt-RNA half-life in these growth
conditions. Also, caution should be exercised when study-
ing mitochondrial gene expression in Hap1 cells cultured in
these different media. When our manuscript was under re-
view, Summer et al. (71) reported that YbeY is involved in
the biogenesis of mt-SSU. Consistent with our result, Sum-
mer et al. showed that YbeY is a mitochondrial protein and
its inactivation in HEK293T-REx cells leads to a decrease in
steady-state levels of mt-SSU protein components, as shown
by western blotting, and reduction of 12S mt-rRNA, exam-
ined by RT-qPCR and RNASeq. On the other hand, and in
line with our data, the analysis of mt-LSU components and
16S mt-rRNA showed no reduction between control and
HEK293T-REx YbeY-KO cells, supporting our conclusion
on YbeY being involved in the biogenesis of mt-SSU.
Analysis of interactors of the human YbeY showed that
it interacts with uS11m. A weaker interaction of YbeY has
been observed for ERAL1. Both uS11m and ERAL1 are
key for mt-SSU biogenesis, suggesting a role for YbeY in
mitoribosomal biogenesis similar to its role in bacteria. The
GTPase ERAL1 is a 12S mt-rRNA chaperone and mt-SSU
assembly factor (21). In bacteria, the homolog of YbeY in-
teracts with ribosomal protein S11 (homolog of mitoriboso-
mal uS11m) through a conserved four stranded beta sheet,
and GTPase Era (homolog of ERAL1). However, the inter-
action with Era is facilitated indirectly through its interac-
tion with S11, which could explain the observed weak inter-
action of ERAL1 with YbeY. A disruption of this YbeY-
S11 interaction in bacteria led to an accumulation of 16S
small subunit rRNA precursors and a resultant increase
in susceptibility to stress (67). The residues involved with
the YbeY-S11 interaction are conserved in human YbeY
(67). Therefore, this suggests that, similar to its bacterial
homolog, YbeY associates with ERAL1 indirectly through
uS11m. Both ERAL1 and its bacterial homolog Era binds
stem-loop structures at the 3′ end of the SSU rRNA (21,22).
In mammalian 12S mt-rRNA, this stem-loop region con-
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tains two adenines that are methylated by TFB1M, and this
modification is necessary for ERAL1 activity (22). The pro-
gression of mt-SSU assembly requires the removal and tar-
geted degradation of ERAL1 from this site (72). Structural
analysis of the mitochondrial ribosome suggests that, sim-
ilar to the bacterial ribosome, the uS11m component is as-
sembled at the 3′ end of the SSU mt-rRNA, at the site of
ERAL1 interaction.
Mitochondrial uS11m has extensive connections with the
12S mt-rRNA and binds independently to other protein
clusters during the assembly process (31). However, previ-
ously published pulse-chase quantitative proteomic analysis
of small subunit assembly in bacteria and human cells have
demonstrated that while the mitochondrial uS11m subunit
is an early binding protein, S11 is one of the last proteins
to be assembled into the bacterial SSU (31,73). In addition
to uS11m, YbeY interactors also included mS26, mL64,
uL2 and early-assembly mt-LSU clusters, bL20m-bL21m-
mL42-mL43-mL44 and uL4m-mL50 (31). Mapping these
components onto the mitoribosomal structures show that
these subcomplexes form a continuous belt of proteins
around the large subunit and have extensive contacts with
the 16S mt-rRNA (Supplementary Figure S6D, E). How-
ever, these interactions with the mt-LSU subcomplexes are
weak and might not be direct, but rather secondary inter-
actions via rRNA or other proteins. These data are consis-
tent with the recent study by Summer et al. (71) who also
report YbeY interaction with mt-LSU components in the
FLIM-FRET (uL24m, bL20m, uL4) and YbeY pull-down
(bL20m, bL21m, uL22m, uL23m, uL24m, bL28m, mL50)
experiments. Many of these mt-LSU proteins are common
for both studies (uL4, bL20m, bL21m, uL24m, bL28m,
mL50). It would be interesting to follow up these observa-
tions, as they may point towards a link between mt-SSU and
mt-LSU biogenesis.
The related study by Summer et al. (71) reported
p32/C1QBP as a YbeY-interacting protein. P32/C1QBP is
a highly abundant protein reported to localize in various
cellular compartments, including the nucleus, nucleoli, cy-
tosol and mitochondria (74–76). This moonlighting pro-
tein has been implicated in inflammation and infection pro-
cesses, regulation of apoptosis, nuclear transcription, pre-
mRNA splicing, autophagy and tumorigenesis, as well as to
have an RNA chaperone role in mitochondria (77–81). Ini-
tially, we pulled-down p32/C1QBP upon overexpression of
YbeY-FLAG/Strep2 (Supplementary Figure S6B). How-
ever, the FLAG tagged version of p32/C1QBP did not co-
purify with YbeY in a reciprocal experiment (Supplemen-
tary Figure S6C). The latter result, however, could be re-
lated to a high abundance of p32/C1QBP and in the ab-
sence of high levels of YbeY overexpression there may
not be enough endogenous YbeY protein to be readily de-
tected by mass spectrometry. Alternatively, the FLAG tag
may interfere with formation of the p32/C1QBP trimer or
with its interaction with YbeY. Importantly, p32/C1QBP
was not found to be enriched in the YbeY SILAC-based,
quantitative immunoaffinity purification experiments (Fig-
ure 5B). It is possible that expression and/or steady-state
level of p32/C1QBP is stimulated by mitochondrial stress
upon overexpression of YbeY, consistent with recent find-
ings on compensatory mechanisms in muscle fibers strug-
gling with metabolic stress (82). Substantial upregulation
of p32/C1QBP, in this case, would cause a non-specific en-
richment in the pull-down experiment and would be subse-
quently identified by mass spectrometry. However, enrich-
ment of p32/C1QBP is not observed in both (HI/LU and
LI/HU) quantitative proteomic experiments. Indeed, in one
of the experiments, p32/C1QBP levels are more abundant
in the control cell line, hence p32/C1QBP is not identified
as enriched. However, we also cannot exclude the possibil-
ity that the inconsistences in SILAC and non-SILAC YbeY
pull-down results stem from the different tags used (non-
SILAC IP: FLAG/Strep2-tag; SILAC IP: FLAG-tag). On
the whole, the role of p32/C1QBP-YbeY interaction in mt-
SSU assembly proposed by Summer et al., based mainly
on immunoaffinity purification and indirect FLIM-FRET
analyses in the conditions of YbeY overexpression, war-
rants further investigations.
Fractionation experiments performed by others are con-
sistent with early mt-LSU assembly and a majority of mt-
SSU assembly occurring in the nucleoid (mtDNA contain-
ing fractions) after which mitoribosome assembly contin-
ues in MRGs, the latter being based on co-localization ex-
periments (19,28,30–32). Our data suggests that YbeY con-
tributes to late assembly of mt-SSU. However, previously
published proteomic analysis of nucleoid-associated pro-
teins did not identify YbeY as a constituent of nucleoids
(28) and our results indicate that YbeY may not localize
to MRGs. The diffuse distribution of YbeY in the mito-
chondrial matrix may be as a result of overexpression of
the protein or its multiple functions in mitochondria. Many
mitochondrial RNA binding proteins, such as MRPP1,
MRPP2 and NSUN4, have multiple independent functions
in RNA modification (17,83–85). Our results have demon-
strated that YbeY, similarly performs multiple independent
functions in the mammalian mitochondria. On the other
hand, these results may point towards a possible functional
link between the post-transcriptional processing of the pri-
mary transcript, mitoribosomal biogenesis and translation
suggested before (29). Moreover, our results also highlight a
possible connection between the assembly pathways of the
large and small mitoribosomal subunits.
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